← Open Payments lookup

KIMBERLY KOVAL: Open Payments

NPI 1083987101 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,229 in 121 payments from 44 companies in 2025. Trend: 2023 $2,970 · 2024 $5,206 · 2025 $3,229

Food & beverage: $1,952Long term medical supply or device loan: $1,000Education: $277
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation23$1,192
AstraZeneca Pharmaceuticals LP11$212
ABBVIE INC.10$164
Incyte Corporation4$157
Janssen Biotech, Inc.4$136
SEAGEN INC.1$100
GlaxoSmithKline, LLC.4$76
PFIZER INC.6$73
Takeda Pharmaceuticals U.S.A., Inc.3$72
E.R. Squibb & Sons, L.L.C.4$68

Products named: KISQALI, ERLEADA, ELAHERE, OPDIVO, Fabhalta, ZYNLONTA, ENHERTU, BRUKINSA.

Industry payments across NJ — which companies pay providers there.